Barely Significant
← all excerpts

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer.

Br J Cancer · 2011 · PMC3111194 · PMID 21587257

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

not quite statistically significantP =0.06so close (0.05 < p ≤ 0.1)
Patients with SD survived longer than those with PD, although this was not quite statistically significant ( P =0.06).

also in 341 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.